Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …
cannabis, cannabinoids, and cannabis based medicines and human health, from …
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
To present a summary of current scientific evidence about the cannabinoid, cannabidiol
(CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders …
(CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders …
Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial
P McGuire, P Robson, WJ Cubala… - American Journal of …, 2018 - Am Psychiatric Assoc
Objective: Research in both animals and humans indicates that cannabidiol (CBD) has
antipsychotic properties. The authors assessed the safety and effectiveness of CBD in …
antipsychotic properties. The authors assessed the safety and effectiveness of CBD in …
Cannabidiol: pharmacology and therapeutic targets
SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - Springer
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
Through the potency monitoring program at the University of Mississippi supported by
National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations …
National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations …
[HTML][HTML] Cannabidiol as a potential treatment for anxiety disorders
EM Blessing, MM Steenkamp, J Manzanares… - …, 2015 - Elsevier
Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …
drug that in recent years has drawn increasing interest as a treatment for a range of …
An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies
K Iffland, F Grotenhermen - Cannabis and cannabinoid research, 2017 - liebertpub.com
Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …
Acute and chronic effects of cannabinoids on human cognition—a systematic review
SJ Broyd, HH Van Hell, C Beale, M Yuecel… - Biological psychiatry, 2016 - Elsevier
Cannabis use has been associated with impaired cognition during acute intoxication as well
as in the unintoxicated state in long-term users. However, the evidence has been mixed and …
as in the unintoxicated state in long-term users. However, the evidence has been mixed and …
[HTML][HTML] Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Cannabidiol is a component of marijuana that does not activate cannabinoid receptors, but
moderately inhibits the degradation of the endocannabinoid anandamide. We previously …
moderately inhibits the degradation of the endocannabinoid anandamide. We previously …
Diversity of molecular targets and signaling pathways for CBD
Cannabidiol (CBD) is the second most abundant component of the Cannabis plant and is
known to have effects distinct from Δ9‐tetrahydrocannabinol (THC). Many studies that …
known to have effects distinct from Δ9‐tetrahydrocannabinol (THC). Many studies that …